Myeloproliferative disorders
J Murray - Clinical medicine, 2005 - ncbi.nlm.nih.gov
The blood count may show a rise in neutrophils in about two-thirds of patients and a
thrombocytosis in 50%. The erythropoietin (EPO) level is characteristically low in PV and …
thrombocytosis in 50%. The erythropoietin (EPO) level is characteristically low in PV and …
[CITATION][C] Myeloproliferative disorders
G Vassiliou, AR Green - Postgraduate Haematology, 2005 - Wiley Online Library
Myeloproliferative Disorders Page 1 761 Introduction For the purposes of this chapter, the term
myeloproliferative disorders (MPDs) will refer to clonal disorders of haemopoiesis that lead to …
myeloproliferative disorders (MPDs) will refer to clonal disorders of haemopoiesis that lead to …
Myeloproliferative diseases
MN Silverstein - Postgraduate Medicine, 1977 - Taylor & Francis
Myeloproliferative diseases Page 1 hematology • rev1ew special series myeloproliferative
diseases Murray N. Sllverstein, MD Maye Clinic and Maye Foundation Rochester …
diseases Murray N. Sllverstein, MD Maye Clinic and Maye Foundation Rochester …
Platelets in the myeloproliferative syndrome
A Weinfeld, I Branehög, J Kutti - Clinics in haematology, 1975 - Elsevier
Among the diseases included in the myeloproliferative syndrome (Dameshek, 1951)
polycythaemia vera (PV), primary thrombocythaemia (PT) and myelofibrosis with myeloid …
polycythaemia vera (PV), primary thrombocythaemia (PT) and myelofibrosis with myeloid …
[CITATION][C] Some speculations on the myeloproliferative syndromes
W Dameshek - Blood, 1951 - ashpublications.org
ACCUMULATING EXIERIENCE, it becomes more and more evident that the bone marrow
cells-enythrobhasts, granulocytes, megakar-vocvtes-often proliferate en masse or as a unit i …
cells-enythrobhasts, granulocytes, megakar-vocvtes-often proliferate en masse or as a unit i …
Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
BH Hyun, GL Gulati, JK Ashton - Clinics in laboratory medicine, 1990 - europepmc.org
Leukocytosis, mild anemia, thrombocytosis, and panhyperplasia in the marrow characterize
the early stages of most of the CMPD, whereas extramedullary hematopoiesis (such as in …
the early stages of most of the CMPD, whereas extramedullary hematopoiesis (such as in …
[CITATION][C] Myeloproliferative diseases. Diagnostic value of the leukocyte alkaline phosphatase test
RD Kolbr, AJ Seaman, EE Osgood… - American Journal of …, 1958 - academic.oup.com
MYELOPROLIFERATIVE DISEASES Clinical and pathologic criteria for sepa- rating one
member of the myeloproliferative syndromes fro Page 1 MYELOPROLIFERATIVE DISEASES …
member of the myeloproliferative syndromes fro Page 1 MYELOPROLIFERATIVE DISEASES …
Myeloproliferative disorders: complications, survival and causes of death
S Brodmann, JR Passweg, A Gratwohl, A Tichelli… - Annals of …, 2000 - Springer
This retrospective single-center study compared thromboembolic and hemorrhagic
complications, survival and causes of death in a cohort of 102 consecutive patients with …
complications, survival and causes of death in a cohort of 102 consecutive patients with …
Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
HS Gilbert - Oncology (Williston Park, NY), 2001 - europepmc.org
Myeloproliferative disorders originate in the clonal expansion of a transformed pluripotential
hematopoietic progenitor cell. This results in a group of syndromes that include …
hematopoietic progenitor cell. This results in a group of syndromes that include …
Myeloproliferative diseases; their shifting spectrums
MN Silverstein - Postgraduate Medicine, 1968 - Taylor & Francis
Myeloid marrow cells can proliferate along different cell lines, and these cells can transform
into one another. Thus polycythemia vera, chronic myelogenous leukemia, agnogenic …
into one another. Thus polycythemia vera, chronic myelogenous leukemia, agnogenic …